Invited Speakers: John Sterling, Managing Editor, Genetic Engineering News
Charles Cooney, Ph.D., MIT
Antonio J. Grillo-Lopez, M.D., Chief Medical Officer,Sr. VP, Med. & Reg. ffairs,
IDEC Pharmaceuticals Corp.
David H. Kirn, M.D., Director of Clinical Research, Onyx Pharmaceuticals
Steve Shak, M.D., Sr. Clinical Scientist, Genentech
Kathryn E. Stein, Ph.D., Director, Division of Monoclonal Antibodies, CBER
Kiki B. Hellman, Ph.D., Sr. Scientist, CDRH-FDA
Philip Noguchi, M.D., CBER
Richard Schoenfeld, Ph.D., Sr. V.P., Engineering & Development, Genzyme
Gordon Pugh, Director of Manufacturing, Lonza Biologics
Kim Nelson, Ph.D., Director of Pharmaceutical Services, Richardson and Biskup
Maura C. Kibbey, Ph.D., Director, IGEN Int. Inc.
Bruce Meiklejohn, Ph.D., Research Scientist, Eli Lilly and Company
William R. Tolbert, Ph.D., Logicon RDA
William J. Fallon, V.P., Serono Laboratories, Inc.
Yashwant N. Deo, Ph.D., V.P. , Operations Medarex, Inc.
Daniel Weese, PhD., Logicon RDA
Julian Cooper, Ph.D., COO, PPL Therapeutics, Inc.
Michelle Kabrin, Process Development Engineer, AMGEN Corp.
Harry Meade, Ph.D., V.P. of Transgenic Research, Genzyme Transgenics Corp.
Willard H. Eyestone, Ph.D., SR. Scientist, Head of Large Animal Technologies,
PPL Therapeutics
Alex Kuta, Ph.D., Director Regulatory Affairs, Genzyme Corp.
James Gilbert, Ph.D., Director of Virology, Panlabs BioSafety
John McEntire, Ph.D., President, BioReliance
Brandon Price, Ph.D., CEO, Croptech Corp
John Maclennan, Ph.D., DYAX Corp.
John Reno, Ph.D., Immunex Corp. (inv)
Richard C. Peet, Esq., Foley & Lardner (inv)
Program:
The US Biotechnology Symposium features 2 Tracks-
Track One: Process Development, Manufacturing and Purification
Track Two: Process Control Monitoring and Validation
Other Topics of The Symposium Include:
Harnessing the Power of Monoclonal Antibodies: The Rituxan Ô Story
The Economics of Manufacturing Recombinant Drugs by Cell Culture
Transgenic Production of Human Recombinant Biopharmaceuticals
Assessment of Viral Safety in the "New" Biopharmaceuticals
Regulating Novel Pharmaceuticals
Process & Product Monitoring of Residual Proteins and Nucleic Acids in Biopharmaceuticals
Process Validation for Biopharmaceutical Production
Regulatory Issues for Transgenic-Derived Human Recombinant Biotherapeutics
Validation Criteria to Meet Regulatory Compliance for Biomolecular Characterization Techniques
Registration :
Contact: Harriet I. Matysko
BioConferences International, Inc.
2 Madison Avenue, Larchmont, NY 10538
Phone: 1 800 5 BIOCON Ext. 608 Fax: 914-834-3689 E-mail: Hmatysko@liebertpub.com
Deadline for Abstracts: 11/15/98
Email for Requests and Registration: Hmatysko@liebertpub.com